Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction.
Saved in:
| Title: | Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction. |
|---|---|
| Authors: | Jorgenson, Margaret R.1 (AUTHOR) MJorgenson@uwhealth.org, Descourouez, Jillian L.1 (AUTHOR), Saddler, Christopher M.2 (AUTHOR), Smith, Jeannina A.2 (AUTHOR), Odorico, Jon S.3 (AUTHOR), Rice, John P.2 (AUTHOR), Mandelbrot, Didier A.2 (AUTHOR) |
| Source: | Clinical Transplantation. Dec2023, Vol. 37 Issue 12, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
